Tuberculin skin test in diagnosis of latent tuberculosis infection

Tomasz J. Kuźniar; Kamilla Kasibowska-Kuźniar; Peter H S Sporn

Tuberculin skin test in diagnosis of latent tuberculosis infection

Tomasz J. Kuźniar^*, Kamilla Kasibowska-Kuźniar, Peter H S Sporn

^*Corresponding author for this work

Medicine, Pulmonary Division

Research output: Contribution to journal › Review article › peer-review

Abstract

Identification and treatment of latent tuberculous infection is one of the important measures to control the incidence of active tuberculosis. The tuberculin skin test is a useful tool in diagnosing latent tuberculous infection in selected high-risk populations. It should be placed only in cases where treatment of latent tuberculosis is considered if the test turns positive. It should not be used as a screening tool in general population, nor should it be employed to detect cases of active tuberculosis. Newer techniques of detection of delayed hypersensitivity to Mycobacteria antigens show promising results. Their current high costs limit their widespread use. The effects of BCG vaccination wane with time, and prior BCG vaccination should not be used as an argument against treatment in high-risk patients.

Original language	English (US)
Pages (from-to)	799-806
Number of pages	8
Journal	Advances in Clinical and Experimental Medicine
Volume	14
Issue number	4
State	Published - Aug 31 2005

Keywords

Latent infection
Tuberculin skin test
Tuberculosis

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{45badb89cd6440089094b81873020856,

title = "Tuberculin skin test in diagnosis of latent tuberculosis infection",

abstract = "Identification and treatment of latent tuberculous infection is one of the important measures to control the incidence of active tuberculosis. The tuberculin skin test is a useful tool in diagnosing latent tuberculous infection in selected high-risk populations. It should be placed only in cases where treatment of latent tuberculosis is considered if the test turns positive. It should not be used as a screening tool in general population, nor should it be employed to detect cases of active tuberculosis. Newer techniques of detection of delayed hypersensitivity to Mycobacteria antigens show promising results. Their current high costs limit their widespread use. The effects of BCG vaccination wane with time, and prior BCG vaccination should not be used as an argument against treatment in high-risk patients.",

keywords = "Latent infection, Tuberculin skin test, Tuberculosis",

author = "Ku{\'z}niar, {Tomasz J.} and Kamilla Kasibowska-Ku{\'z}niar and Sporn, {Peter H S}",

year = "2005",

month = aug,

day = "31",

language = "English (US)",

volume = "14",

pages = "799--806",

journal = "Advances in Clinical and Experimental Medicine",

issn = "1230-025X",

publisher = "Wroclaw Medical University",

number = "4",

}

TY - JOUR

T1 - Tuberculin skin test in diagnosis of latent tuberculosis infection

AU - Kuźniar, Tomasz J.

AU - Kasibowska-Kuźniar, Kamilla

AU - Sporn, Peter H S

PY - 2005/8/31

Y1 - 2005/8/31

N2 - Identification and treatment of latent tuberculous infection is one of the important measures to control the incidence of active tuberculosis. The tuberculin skin test is a useful tool in diagnosing latent tuberculous infection in selected high-risk populations. It should be placed only in cases where treatment of latent tuberculosis is considered if the test turns positive. It should not be used as a screening tool in general population, nor should it be employed to detect cases of active tuberculosis. Newer techniques of detection of delayed hypersensitivity to Mycobacteria antigens show promising results. Their current high costs limit their widespread use. The effects of BCG vaccination wane with time, and prior BCG vaccination should not be used as an argument against treatment in high-risk patients.

AB - Identification and treatment of latent tuberculous infection is one of the important measures to control the incidence of active tuberculosis. The tuberculin skin test is a useful tool in diagnosing latent tuberculous infection in selected high-risk populations. It should be placed only in cases where treatment of latent tuberculosis is considered if the test turns positive. It should not be used as a screening tool in general population, nor should it be employed to detect cases of active tuberculosis. Newer techniques of detection of delayed hypersensitivity to Mycobacteria antigens show promising results. Their current high costs limit their widespread use. The effects of BCG vaccination wane with time, and prior BCG vaccination should not be used as an argument against treatment in high-risk patients.

KW - Latent infection

KW - Tuberculin skin test

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=23844543071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844543071&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:23844543071

VL - 14

SP - 799

EP - 806

JO - Advances in Clinical and Experimental Medicine

JF - Advances in Clinical and Experimental Medicine

SN - 1230-025X

IS - 4

ER -

Tuberculin skin test in diagnosis of latent tuberculosis infection

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this